Pete Pharma’s partnership with FABRX marks a significant advancement for the U.S. compounding pharmacy sector, bringing cutting-edge pharmaceutical 3D printing technology into the commercial landscape.
PHOENIX–(BUSINESS WIRE)–Pete Pharma announced today a groundbreaking partnership with FABRX, the global pioneer of pharmaceutical 3D printing, to introduce this innovative technology to the U.S. compounding pharmacy market. FABRX, founded over a decade ago, has successfully deployed pharmaceutical 3D printing across hospitals, universities, and clinical research centers worldwide. Pete Pharma will leverage this deep foundation of scientific validation to bring the technology into a commercial
Source: Original Press Release
